RMP-A03 Ocular Suspension in Patients With Pterygium

Status:
Not yet recruiting

Trial end date:
2024-02-01

Target enrollment:

Participant gender:

The goal of this clinical trial is to test the safety and efficacy of an ocular medication on the treatment of pterygium.

Phase 2

Suzhou Raymon Pharmaceuticals Company, Ltd.

WuXi Clinical